ABSTRACT Electrical stimulation of the superior cervical ganglia causes a rapid increase in the concentration ofcyclic AMP in the pineal gland of rats. This effect is dependent upon the frequency, voltage, and duration of the stimulus and is markedly potentiated by pretreating the animals with desmethylimipramine. The increase in cyclic AMP is blocked by prior treatment of the rats with reserpine, bretylium, or propanolol but not with phentolamine. These results provide direct evidence that electrical stimulation ofsympathetic nerves increases cyclic AMP in a target organ through the release ofnorepinephrine from presynaptic terminals acting on postsynaptic P-adrenergic receptors. (3) (4) (5) . In those cases in which cyclic AMP was increased, the changes were small and inconsistent and were not totally or specifically inhibited by ,-adrenergic blocking drugs (4).
It was predicted about 2 decades ago that electrical stimulation of the sympathetic nerves innervating a tissue would cause an increase in cyclic AMP in that tissue. Although many of the other criteria for implicating cyclic AMP in the transsynaptic actions ofnorepinephrine have been demonstrated experimentally, it has not yet been shown conclusively that direct electrical stimulation of sympathetic nerves leads to an increase in the concentration of cyclic AMP in tissues innervated by these; nerves (see refs. 1 and 2). This remains a missing link in the theory that cyclic AMP mediates the synaptic effect of norepinephrine on end organs. Previous studies attempting to show an increased concentration ofcyclic AMP in cerebellum or cerebral cortex induced by electrical stimulation ofthe locus ceruleus have produced conflicting results (3) (4) (5) . In those cases in which cyclic AMP was increased, the changes were small and inconsistent and were not totally or specifically inhibited by ,-adrenergic blocking drugs (4) .
The recent finding that the in vivo administration of norepinephrine to rats failed to increase the concentration ofcyclic AMP in pineal gland except when given after the tricyclic antidepressant drug desmethylimipramine (6) , which prevents the reuptake ofthe catecholamine into sympathetic nerve terminals (7) , suggested that one may be able to demonstrate an increase ofcyclic AMP induced by nerve stimulation more readily in rats pretreated with desmethylimipramine.
The pineal gland should be a good model for demonstrating whether direct sympathetic nerve stimulation does increase the concentration ofcyclic AMP in tissues supplied by these nerves. This gland is richly innervated by sympathetic fibers originating exclusively from the superior cervical ganglia (8) , it contains a high density of &adrenergic receptors coupled to adenylate cyclase (9) , and it possesses an adenylate cyclase system which, when activated by catecholamines (10) , results in a marked increase in the intracellular concentration of cyclic AMP (11) .
The present results demonstrate that electrical stimulation of the superior cervical ganglia produces a rapid and marked increase in the concentration of cyclic AMP in rat pineal gland of animals treated with desmethylimipramine.
METHODS
Male Sprague-Dawley rats (300-500 g), purchased from Zivic Miller Laboratories (Allison Park, PA), were allowed free access to food and water. They were housed in an environmental chamber (Hotpack, Philadelphia, PA) and were kept in constant light for at least 6 days prior to the experiment, a procedure which increases the sensitivity of the catecholamine-sensitive adenylate cyclase system of pineal gland (12) . Either saline or desmethylimipramine was given intraperitoneally 1 hr prior to stimulation of the superior cervical ganglia. Unless otherwise indicated, desmethylimipramine was given at a dose of38 Zmol/ kg (10 mg/kg).
To stimulate the superior cervical ganglia, the animals were decapitated, the head was washed with cold saline to remove excess blood, and both superior cervical ganglia were isolated and attached to platinum bipolar electrodes connected to Grass SD-9 square-wave stimulators. Stimulation began within 60 sec of decapitation. In all cases, control animals had electrodes attached to the ganglia, but no current was applied. After stimulation, the pineal gland was removed from the skull and frozen on dry ice within 20 sec of the cessation of stimulation.
Cyclic AMP content of the pineal gland was analyzed by radioimmunoassay as described (6) . To measure the concentration ofdesmethylimipramine in plasma, blood was collected in tubes containing heparin, and the blood was centrifuged at 2000 X g for 15 min at 4°C. The concentration of desmethylimipramine in the plasma was measured by radioimmunoassay as described (6) . Statistical analyses were performed by the Student's t test unless indicated otherwise. Table 1 shows the effect ofelectrical stimulation ofthe superior cervical ganglia on the concentration ofcyclic AMP ofrat pineal gland. Supramaximal stimulation (20 V, 10 Hz, 10 msec per pulse) ofthe ganglia for 1 min produced a statistically significant increase in the concentration of cyclic AMP of the gland. Pretreating the animals with desmethylimipramine raised the basal concentration of cyclic AMP and markedly potentiated the increase in cyclic AMP concentrations induced by nerve stimulation. Under these conditions, the concentration ofcyclic AMP in the pineal gland ofrats pretreated with desmethylimipramine increased more than 4-fold after ganglionic stimulation. Electrical stimulation of the ganglia by using lower and more physiological stimulation conditions failed to elicit consistent increases in cyclic AMP in rats not given desmethylimipramine (see Fig. 2 ). However, desmethylimipramine-treated rats
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When the frequency was kept constant at 10 Hz and the pulse duration kept at 1 msec, a significant increase in cyclic AMP was produced with a stimulus of 5 V. Maximal increases in cyclic AMP were seen with 10 V, and no further increase was produced when the voltage was increased to 20 V. With 10 V and 10 Hz, a stimulus duration of 1 msec produced maximal increases in cyclic AMP in the pineal gland. Therefore, subsequent experiments were performed with stimulation at 10 V and 1 msec per pulse. Fig. 1 Upper shows the effect ofthe frequency ofstimulation on the increase in cyclic AMP in pineal gland. A significant increase was seen with a frequency as low as 2.5 Hz. A maximal increase, about 4-fold, was produced at 10 Hz. Fig. 1 10 Hz, and 1 msec per pulse for a total stimulation time of1 min. To determine if the increase in cyclic AMP in pineal gland seen after stimulation of the ganglia in desmethylimipraminetreated rats was due to norepinephrine released from sympathetic nerve terminals activating 1&adrenergic receptors in this gland, we examined the influences of various pharmacological agents on the increase in cyclic AMP induced by nerve stimulation. Control rats (i.e., injected with 0.9% sodium chloride) exhibited no increase in cyclic AMP upon ganglionic stimulation (Fig. 2) . Cyclic AMP increased markedly upon ganglionic stimulation of rats treated with desmethylimipramine. Reserpine, which depletes norepinephrine in sympathetic nerve terminals (13) , decreased the concentration ofcyclic AMP in pineal gland when administered alone and completely prevented the increase upon ganglionic stimulation of rats treated with desmethylimipramine. Bretylium, which inhibits the release of norepinephrine caused by nerve stimulation (14) , did not-alter the levels of cyclic AMP when administered alone. However, when it was given to rats subsequently treated with desmethy- limipramine, it reduced the increase in cyclic AMP caused by ganglionic stimulation compared to that in rats treated only with desmethylimipramine (P < 0.05).
The type of adrenergic receptor on the pineal gland that is responsible for the increase in cyclic AMP was examined by pretreating animals with either an a-or a (3-adrenergic antagonist (Fig. 2) . Pretreating rats with the /3 antagonist (+)propranolol decreased the content ofcyclic AMP in the pineal gland when given alone; when administered prior to desmethylimipramine, propranolol, like reserpine, blocked completely the increase in cyclic AMP induced by ganglionic stimulation. The a-adrenergic antagonist phentolamine had no effect on the basal concentration of cyclic AMP but potentiated the increase in cyclic AMP upon stimulation of the ganglia. When phentolamine was given to rats before desmethylimipramine, ganglionic stimulation produced an increase in pineal cyclic AMP equivalent to that in rats treated only with desmethylimipramine. Fig. 3 shows the effect of different doses of desmethylimipramine on the increase in cyclic AMP in the pineal gland after stimulation of the superior cervical ganglia. Doses of desmethylimipramine as low as 0.625 mg/kg (2.4 umoVkg) produced an almost 3-fold (P < 0.05) increase in cyclic AMP. Maximal increases in cyclic AMP in the pineal after ganglionic stimulation occurred at 2.5 mg/kg (9.6 Amol/kg). Although producing linear increases in the plasma concentration of the drug, higher doses of desmethylimipramine failed to produce further increases in the concentration ofcyclic AMP in the pineal gland. though, it appears necessary to use an inhibitor of the uptake ofnorepinephrine, such as desmethylimipramine. Under these conditions, electrical stimulation ofthe superior cervical ganglia produces more than a 4-fold increase in the concentration of cyclic AMP in the pineal gland.
That the increase in cyclic AMP in the pineal gland induced by electrical stimulation of the superior cervical ganglia results from the activation of pineal (3-adrenergic receptors by norepinephrine released from noradrenergic nerves is supported by the following observations: reserpine, which depletes norepinephrine from noradrenergic nerves (13) , prevented the increase in cyclic AMP induced by nerve stimulation; bretylium, which-inhibits the release ofnorepinephrine due to stimulation of noradrenergic-nerves (14) , reduced the increase in cyclic AMP due-to ganglionic stimulation; and propranolol, which blocks postqunctional P-adrenergic receptor sites (15) , likewise blocked the increase in the cyclic nucleotide in the pineal gland. Conversely, the a-adrenergic antagonist phentolamine failed to prevent the increase in cyclic AMP. In fact, in rats given phentolamine alone, ganglionic stimulation caused a significant increase of cyclic AMP in the pineal gland.
The potentiating effect of phentolamine on the increase in cyclic AMP induced by ganglionic stimulation may be related to its ability to block the uptake of norepinephrine (16) .. However, the dose of phentolamine used in our experiments apparently does not block the uptake of this catecholamine (17) . Rather, this effect ofphentolamine may be related to its ability to block presynaptic a-adrenergic receptors on the sympathetic terminals innervating the pineal gland. Pharmacological evidence for the existence of such receptors in the pineal has been presented (18, 19) Alternatively, it is possible that a-adrenergic receptors on some pinealocytes (21) mediate an inhibitory effect on cyclic AMP formation which would tend to mask stimulation ofcyclic AMP due to activation of ,&receptors. Blockade of such a-adrenergic receptors by phentolamine would prevent this inhibitory effect.
In view of the importance of the concept that cyclic AMP might mediate the synaptic effect of norepinephrine, together with the long-standing observation that catecholamines increase the concentration of cyclic AMP in tissues (1), the absence of a clear-cut demonstration that electrical stimulation of noradrenergic nerves increases end-organ concentrations of cyclic AMP is somewhat surprising. It is unlikely that the relative lack of evidence demonstrating this is due to the experiment not being attempted. However, we are not aware of any reports demonstrating an increase in end-organ concentrations ofcyclic AMP upon electrical stimulation of peripheral noradrenergic nerves. Siggins et al. (3) , using an immunofluorescent technique for measuring cyclic AMP, found that electrical stimulation of the locus-ceruleus increased the cyclic AMP concentration in cerebellar Purkinje cells. However, there is some uncertainty as to how quantitative the immunocytochemical technique for cyclic AMP is (22) . More recently, Korf and Sebens (4) reported that electrical stimulation ofthe locus ceruleus of rats caused an increase of about 25% in the concentration of cyclic AMP in the frontal cortex. Interestingly, this increase of cortical cyclic AMP was not blocked by either propranolol or phenoxybenzamine administered alone. The inability to demonstrate large increases in cyclic AMP in the cerebral cortex upon stimulation ofthe locus ceruleus, even in rats treated with desmethylimipramine (5), may be explained by the relatively low density of ,&adrenergic receptors in cerebral cortex compared with that in the pineal gland (9) and by the relatively high activity of cyclic AMP phosphodiesterase in cortex in comparison with that of the pineal (23) .
It is curious why an inhibitor ofthe uptake ofnorepinephrine is necessary to demonstrate consistent and large increases in tissue concentrations ofcyclic AMP upon electrical stimulation ofnoradrenergic nerves. Biochemical events that are known to be mediated by cyclic AMP can be induced by stimulating noradrenergic nerves in the absence of an inhibitor of the uptake of norepinephrine (24) (25) (26) . Similarly, physiological activation of the noradrenergic fibers to the pineal caused by darkness (27) increases N-acetyltransferase activity in pineal gland (28) ; in order to demonstrate a darkness-induced increase in cyclic AMP in the gland, though, it was necessary to pretreat the rats with desmethylimipramine (29) .
This apparent discrepency between the effect of noradrenergic nerve stimulation on tissue levels ofcyclic AMP and responses mediated by the cyclic nucleotide may be due to the fact that only small and transient increases in cyclic AMP are required to produce longer-term changes in enzyme activity. Perhaps only a small and sometimes technically unmeasureable increase in cyclic AMP is necessary to initiate a cascade ofprocesses mediated by the cyclic nucleotide. However, if there is a sustained increase in the concentration of norepinephrine in the synapse, caused by the inhibition of uptake of the biogenic amine, there may be sufficient activation of adenylate cyclase to produce measureable increases in cyclic AMP. Thus, uptake inhibitors such as desmethylimipramine may be useful tools to demonstrate effects of nerve stimulation on the concentration of cyclic AMP in sympathetically innervated tissues.
In conclusion, the evidence presented here-that electrical stimulation ofthe sympathetic nerves innervating the rat pineal gland causes an increase in the concentration of cyclic AMP in this gland-provides the missing link in a sequence of events that must be established to demonstrate that this cyclic nucleotide mediates the effects of sympathetic nerve stimulation.
